Company: IRadimed Corporation
Ticker: Nasdaq: IRMD
Sector: Healthcare
Investor Contact: Joe Dorame

IRadimed Corporation News

News

IRADIMED CORPORATION to Participate at Upcoming Investor Conferences

WINTER SPRINGS, Fla., Sept. 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the H.C....

IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results

Reports record revenue of $16.1 million for the second quarter of 2023GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36Operating income was $5.0 million and increased by 19%Announces third quarter and full year 2023 financial guidance WINTER SPRINGS, Fla.,...

IRADIMED CORPORATION Announces First Quarter 2023 Financial Results

Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% Announces second quarter 2023 financial guidance and increases full-year...

IRADIMED CORPORATION To Present at the 35th Annual Roth Conference

WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...

IRADIMED CORPORATION Issues Urgent Medical Device Correction

Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter SetWINTER SPRINGS, Fla., Feb. 24, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...

Skip to content